JLK,INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,960 KRW | +3.25% |
|
-4.84% | -36.40% |
| 2023 | JLK,Inc.(KOSDAQ:A322510) added to S&P Global BMI Index | CI |
| 2023 | JLK Inc. Unveils Its AI-Powered Imaging Diagnosis Solutions for Stroke | CI |
| Sales 2022 | 3.42B 2.47M | Sales 2023 | 2.49B 1.8M | Capitalization | 348B 251M |
|---|---|---|---|---|---|
| Net income 2022 | -9.01B -6.51M | Net income 2023 | -7.32B -5.29M | EV / Sales 2022 | 16.3 x |
| Net Debt 2022 | 8.31B 6M | Net Debt 2023 | 11.95B 8.63M | EV / Sales 2023 | 144 x |
| P/E ratio 2022 |
-5.21
x | P/E ratio 2023 |
-46.8
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.21% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.25% | ||
| 1 week | -4.84% | ||
| Current month | -4.25% | ||
| 1 month | -11.70% | ||
| 3 months | +31.82% | ||
| 6 months | -32.88% | ||
| Current year | -36.40% |
1 week
13 200.00
14 270.00
1 month
12 230.0018 280.00
Current year
8 990.0024 900.00
1 year
8 990.0039 050.00
3 years
3 100.0039 050.00
5 years
3 100.0039 050.00
10 years
3 100.0039 050.00
| Managers | Title | Age | Since |
|---|---|---|---|
Dong-Min Kim
CEO | Chief Executive Officer | 47 | - |
Won-Tae Kim
FOU | Founder | 59 | 14-02-17 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Won-Tae Kim
FOU | Founder | 59 | 14-02-17 |
Dong-Min Kim
CEO | Chief Executive Officer | 47 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-08 | 13,960 | +3.25% | 183,120 |
| 24-07-05 | 13,520 | -1.31% | 345,778 |
| 24-07-04 | 13,700 | -0.58% | 195,970 |
| 24-07-03 | 13,780 | -2.61% | 230,228 |
| 24-07-02 | 14,150 | -3.54% | 247,434 |
End-of-day quote Korea S.E., July 07, 2024
More quotes
JLK Inc, formerly JLK Inspection Inc, is a Korea-based company principally engaged in the development of artificial intelligence (AI) software. The Company develops software including AI medical analysis solutions, AI industry and security analysis solutions and others. Medical diagnostic platforms consist of AI medical systems, AI quantitative analysis platforms, AI remote platforms, AI medical diagnostic platforms, among others.
Sector
Software
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -36.40% | 155M | |
| +23.99% | 3,475B | |
| +19.53% | 95.19B | |
| +16.52% | 88.04B | |
| +61.33% | 60.64B | |
| -19.70% | 50.89B | |
| +37.69% | 48.86B | |
| -23.57% | 48.76B | |
| +80.15% | 41.28B | |
| -5.56% | 26.56B |
- Stock Market
- Equities
- A322510 Stock
